Why a Radioligand No-Show Costs Differently Than a Missed Fraction.

from Medsolve Dynamics · host Medsolve Dynamics

Lutetium-177 has a half-life of about 6.6 days, so a radioligand therapy no-show is a paid dose decaying in your department. The dose economics behind theranostics scheduling and isotope supply. medsolvedynamics.com | [email protected] #Theranostics #RadioligandTherapy #IsotopeSupply #OncologyOperations

Episode metadata supplied by the publisher feed · Published Jun 11, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Why a Radioligand No-Show Costs Differently Than a Missed Fraction.

0:00 1:29

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medsolve Dynamics?

This episode is 1 minute long.

When was this Medsolve Dynamics episode published?

This episode was published on June 11, 2026.

Can I download this Medsolve Dynamics episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!